# AMPHETAMINE SULFATE
> **ANDA211861** · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2020-03-11
## Drug
- **FDA Application Number:** ANDA211861
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMPHETAMINE SULFATE
- **Generic name:** AMPHETAMINE SULFATE
- **Active ingredients:** AMPHETAMINE SULFATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PRINSTON INC
- **Manufacturer:** Solco Healthcare US, LLC
- **First approval:** 2020-03-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211861)
---
*AI Analytics · CC0 1.0*